
© Natural Society
The biotech firm Editas Medicine says that humans who have had their DNA genetically modified could exist within the next 2 years. The company announced that it will soon start the first trials of what it calls a groundbreaking new technique.
U.S.-based Editas is striving to become the first lab in the world to edit the DNA of patients suffering from
leber congenital amaurosis (LCA), a genetic condition that causes severe vision loss at birth. Some LCA patients also experience central nervous system conditions, such as epilepsy, developmental delays and motor skill impairment.
LCA is said to be caused by defects in a gene responsible for the creation of a protein that is vital to vision. Editas Medicine scientists believe they can fix the mutated DNA using gene-editing technology known as CRISPRs.
CRISPRs, which stands for "clustered regularly interspaced short palindromic repeats," allows scientists to edit genes "with precision, efficiency and flexibility,"
Gizmodo explained in a May 5, 2015 article. Researchers have reportedly been able to create
monkeys with targeted mutations and
prevent HIV infection in human cells using this piece of biotechnology.
In early May, Chinese scientists said they'd successfully applied CRISPRs to nonviable human embryos, suggesting that the technology could someday be used to treat any genetic disease. It might even be used to create "
designer babies" in the future, though that day is a long ways off.
Editas Medicine hopes to start a CRISPR trial with blind patients in 2017. It would be the first time the technology was ever used on humans.
Comment: Babies have an eye for statistics
Babies And Beethoven: Infants Can Tell Happy Songs From Sad